Earnings Releases·Oct 28, 2026, 7:01 AM ET

IDEX Corporation — Third Quarter 2026 Earnings Summary

Reported record net sales of $951.7 million (up 8% YoY) and adjusted diluted EPS of $2.33 (up 15% YoY), driven by strong order growth of 13% YoY to $991.2 million and margin expansion across all segments.
Raised full-year organic sales growth guidance to 6.5%–6.8% and adjusted diluted EPS guidance to $8.91–$8.96, citing improved visibility and momentum.
Returned $129 million to shareholders via $54.0 million in dividends and $74.6 million in stock repurchases; amended the $800 million revolving credit facility to extend maturity to September 2031.
Health & Science Technologies segment led growth with 14% sales increase, while Fluid & Metering and Fire & Safety/Diversified Products segments posted 3% and 5% growth respectively, supported by pricing and volume leverage.